A new era of reconstructive polymers
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures:
To reconstruct damaged tissue and restore its natural function.
Biomorphic programmable polymers
Our proprietary biomorphic programmable polymers enable tissue reconstruction and can be adapted for use in multiple clinical areas
Biomorphic
Conforms to and integrates with surrounding tissue to enable tissue reconstruction
Programmable
Polymer building blocks can be adjusted to match tissue-specific requirements
Therapeutic areas
We design solutions for different tissue types for both open surgery and minimally invasive procedures
Peripheral Nerve
Cardiovascular
Gastrointestinal
Achievements
3
CE Marks
64
Patents Granted
37
Patents Pending
9
Publications
